Cargando…
Antimyostatin Treatment in Health and Disease: The Story of Great Expectations and Limited Success
In the past 20 years, myostatin, a negative regulator of muscle mass, has attracted attention as a potential therapeutic target in muscular dystrophies and other conditions. Preclinical studies have shown potential for increasing muscular mass and ameliorating the pathological features of dystrophic...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001237/ https://www.ncbi.nlm.nih.gov/pubmed/33802348 http://dx.doi.org/10.3390/cells10030533 |